A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption [PDF]
Medicina, 2021 Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj +8 more sources
Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis [PDF]
Frontiers in Medicine, 2023 Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without ...
Maren Paulmann +3 more
doaj +8 more sources
Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned! [PDF]
Clinical Case ReportsFixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well‐defined erythematous to violaceous patch that recurs at the same site upon re‐exposure to causative drugs and resolves with hyperpigmentation.
Mahesh Mathur +4 more
doaj +7 more sources
Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption [PDF]
Clinical, Cosmetic and Investigational DermatologyYuanyuan Wang,1,* Huan Xue,2,* Hejun Dai,1 Lianjuan Yang1 1Department of Medical Mycology, Center of Infectious Skin Diseases, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China; 2Department
Wang Y, Xue H, Dai H, Yang L
doaj +6 more sources
Cyclosporine in generalized bullous-fixed drug eruption
Indian Journal of Dermatology, 2018 Sir, Generalized bullous-fixed drug eruption (GBFDE), is a severe form of FDE characterized by widespread blisters and erosions, involving the whole body in addition to lesions typical of FDE. Although GBFDE is believed to have a favorable prognosis, the
Ranjana Beniwal +5 more
doaj +5 more sources
Generalized bullous fixed-drug eruption secondary to the influenza vaccine [PDF]
JAAD Case Reports, 2018 Fixed drug eruption (FDE) is a type IV hypersensitivity reaction characterized by recurrence of lesions at identical sites with each exposure to the offending medication.
Marni Mcclure
exaly +6 more sources
Cefotaxime induced generalized bullous fixed drug eruption - A case report [PDF]
Toxicology Reports, 2018 Fixed drug eruption (FDE) is the most common cutaneous adverse drug reaction. Cefotaxime, a broad-spectrum third-generation cephalosporin, appeared to be a safe and effective therapy in greater than 90% of infections including cellulitis, abscesses and ...
R. Manikandan +6 more
doaj +6 more sources
Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndrome [PDF]
Baylor University Medical Center Proceedings, 2019 A 59-year-old woman with end-stage renal disease presented for suspected Stevens-Johnson syndrome that was ultimately diagnosed as generalized bullous fixed drug eruption (GBFDE) secondary to the administration of iodinated nonpolar radiocontrast.
Cloyce Stetson, Meredith Gavin
exaly +6 more sources
Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review [PDF]
Case Reports in Dermatological Medicine, 2023 Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases.
Bahareh Abtahi-Naeini +4 more
doaj +3 more sources
Severe Generalized Bullous Fixed Drug Eruption Treated with Cyclosporine: A Case Report and Literature Review [PDF]
Case Reports in Dermatology, 2021 Generalized bullous fixed drug eruptions (GBFDEs) are rare in the paediatric population. We present the case of a 7-year-old girl with GBFDE believed to be secondary to oral ibuprofen, who experienced rapid resolution of lesions and cessation of ...
Hailey C. Barootes +5 more
doaj +3 more sources